Early Detection & Relapse Tracking for TMS Patients
Protect outcomes. Recover revenue. Improve patient care.
Why Early Detection After TMS Matters
Transcranial Magnetic Stimulation (TMS) delivers strong response and remission rates—but depression is a relapsing condition, not a one-time event.
~20% Relapse Rate
of TMS responders relapse within 12 months
85%+ Response Rate
of prior responders respond again to retreatment
Missed Relapses
Most relapses are missed until symptoms are severe
Patient Disengagement
Patients often disengage before asking for help
The problem isn't retreatment effectiveness.
The problem is early detection and follow-up.
TouchpointHQ solves this gap.
Early Detection Pays for Itself
See the financial impact of retaining relapsing TMS patients
Your Clinic Numbers
Return on Investment
Annual ROI with TouchpointHQ
Patients Returning
0
for retreatment
Additional Revenue
$200,000
per year
TouchpointHQ Cost: $360/year
One recovered patient pays for TouchpointHQ for years.
What Early Detection Looks Like in Practice
TouchpointHQ enables clinics to:
Automatically track post-TMS patients at 30 / 60 / 90 / 180 / 365 days
Use standardized symptom scales (PHQ-9, GAD-7, etc.)
Detect subclinical symptom drift before full relapse
Trigger timely outreach—before patients disappear
Document outcomes for clinical quality & payor negotiations
This is not marketing automation.
This is outcomes intelligence.
The Clinical Reality of TMS Relapse
Depression relapse rarely happens overnight
Symptoms worsen gradually over weeks to months, making early detection crucial for optimal outcomes.
Early intervention benefits
- Shortens retreatment duration
- Improves patient confidence
- Prevents full functional decline
- Preserves long-term remission
Tracking ≠ surveillance
Tracking = continuity of care.
Benefits Beyond Revenue
What clinics actually care about
Better Patient Outcomes
- Earlier intervention
- Shorter symptom duration
- Higher long-term remission rates
Stronger Patient Retention
- Patients feel supported post-treatment
- Clinics stay connected after discharge
- Fewer patients "lost to follow-up"
Payor & Contracting Leverage
Outcome data by treatment type, time since completion, and insurance payor supports:
- Rate negotiations
- Value-based discussions
- Medical necessity narratives
Operational Clarity
- Know who needs outreach today
- Know who is stable
- Know who is trending down before crisis
Why TouchpointHQ Is Different
Most systems stop at:
- Intake
- Discharge
- Static notes
TouchpointHQ is built for:
- Longitudinal outcomes
- Post-interventional psychiatry
- Relapse detection
- Retreatment optimization
It is not an EMR.
It is the missing outcomes layer.
Neurostimulation: Treating the Axon
Understanding how TMS differs from traditional medication
Medications
Most medications work by modulating neurotransmitter activity at the synaptic level.
Neurostimulation (TMS)
Neurostimulation acts directly on axons and dendrites via electrical/magnetic fields.
Other neurostimulation interventions include:
ECT, tDCS, DBS
Who Is a Good Candidate for TMS?
Ideal Candidates
Patients with MDD (single or recurrent), moderate or severe episodes, who have failed 2 or more antidepressants.
Note: TMS is not covered but effective for bipolar disorder.
Risk Assessment
- Seizure disorder history
- Ferromagnetic object in head
- Active substance use disorder
- High benzodiazepine load
Safety and Tolerability
Seizure Risk
Since 2008: 7 seizures out of 250,000 treatments on the Neurostar system.
- ~1/30,000 treatments or 1/1,000 patients (0.1%)
- Less seizure risk than antidepressant therapy (e.g., Wellbutrin)
- Screen for factors that lower seizure threshold (sleep deprivation, etc.)
Side Effects
Headache (20-30%) and scalp discomfort (~20%). Usually self-resolving.
Excellent Tolerability
- No recovery time: patients can drive home and return to work immediately
- No systemic side effects (unlike medications)
TMS Frequently Asked Questions
Everything you need to know about Transcranial Magnetic Stimulation
TMS works.
Patients relapse.
Prior responders respond again.
The only variable clinics control is how early they know.
TouchpointHQ ensures you know early—
clinically, operationally, and financially.
First 5 Patients Free Forever
Then just $29.99/month for unlimited patients
Get Started FreeNo credit card required • HIPAA compliant • Setup in minutes